These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9516080)

  • 21. The insulin-like growth factor-I receptor (IGF-IR) in breast cancer: biology and treatment strategies.
    Motallebnezhad M; Aghebati-Maleki L; Jadidi-Niaragh F; Nickho H; Samadi-Kafil H; Shamsasenjan K; Yousefi M
    Tumour Biol; 2016 Sep; 37(9):11711-11721. PubMed ID: 27444280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.
    Law JH; Habibi G; Hu K; Masoudi H; Wang MY; Stratford AL; Park E; Gee JM; Finlay P; Jones HE; Nicholson RI; Carboni J; Gottardis M; Pollak M; Dunn SE
    Cancer Res; 2008 Dec; 68(24):10238-46. PubMed ID: 19074892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential roles of IRS-1 and SHC signaling pathways in breast cancer cells.
    Nolan MK; Jankowska L; Prisco M; Xu S; Guvakova MA; Surmacz E
    Int J Cancer; 1997 Sep; 72(5):828-34. PubMed ID: 9311601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.
    Song RX; Zhang Z; Chen Y; Bao Y; Santen RJ
    Endocrinology; 2007 Aug; 148(8):4091-101. PubMed ID: 17525128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor.
    Knowlden JM; Hutcheson IR; Barrow D; Gee JM; Nicholson RI
    Endocrinology; 2005 Nov; 146(11):4609-18. PubMed ID: 16037379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
    Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
    Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IGF-I/EGF and E2 signaling crosstalk through IGF-IR conduit point affects breast cancer cell adhesion.
    Voudouri K; Nikitovic D; Berdiaki A; Kletsas D; Karamanos NK; Tzanakakis GN
    Matrix Biol; 2016 Dec; 56():95-113. PubMed ID: 27353258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type I insulin-like growth factor receptor over-expression induces proliferation and anti-apoptotic signaling in a three-dimensional culture model of breast epithelial cells.
    Yanochko GM; Eckhart W
    Breast Cancer Res; 2006; 8(2):R18. PubMed ID: 16584539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.
    Maor S; Mayer D; Yarden RI; Lee AV; Sarfstein R; Werner H; Papa MZ
    J Endocrinol; 2006 Dec; 191(3):605-12. PubMed ID: 17170218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
    Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
    Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of human breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor inhibits cell growth, suppresses tumorigenesis, alters the metastatic potential, and prolongs survival in vivo.
    Chernicky CL; Yi L; Tan H; Gan SU; Ilan J
    Cancer Gene Ther; 2000 Mar; 7(3):384-95. PubMed ID: 10766344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of insulin-like growth factor I receptor-mediated pathway by ginsenoside Rg1.
    Chen WF; Lau WS; Cheung PY; Guo DA; Wong MS
    Br J Pharmacol; 2006 Mar; 147(5):542-51. PubMed ID: 16415910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells.
    Bentel JM; Lebwohl DE; Cullen KJ; Rubin MS; Rosen N; Mendelsohn J; Miller WH
    J Cell Physiol; 1995 Oct; 165(1):212-21. PubMed ID: 7559803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer.
    Elbaz M; Ahirwar D; Ravi J; Nasser MW; Ganju RK
    Oncotarget; 2017 May; 8(18):29668-29678. PubMed ID: 27213582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of fascin spikes in breast cancer cells by activation of the insulin-like growth factor-I receptor.
    Guvakova MA; Boettiger D; Adams JC
    Int J Biochem Cell Biol; 2002 Jun; 34(6):685-98. PubMed ID: 11943599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.
    Lee AV; Jackson JG; Gooch JL; Hilsenbeck SG; Coronado-Heinsohn E; Osborne CK; Yee D
    Mol Endocrinol; 1999 May; 13(5):787-96. PubMed ID: 10319328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-like growth factor receptor expression and function in human breast cancer.
    Cullen KJ; Yee D; Sly WS; Perdue J; Hampton B; Lippman ME; Rosen N
    Cancer Res; 1990 Jan; 50(1):48-53. PubMed ID: 2152773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of insulin-like growth factor I receptor function inhibits growth and angiogenesis of colon cancer.
    Reinmuth N; Liu W; Fan F; Jung YD; Ahmad SA; Stoeltzing O; Bucana CD; Radinsky R; Ellis LM
    Clin Cancer Res; 2002 Oct; 8(10):3259-69. PubMed ID: 12374697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
    Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of the insulin-like growth factor-I receptor in primary breast cancer and lymph node metastases: correlations with estrogen receptors alpha and beta.
    Koda M; Sulkowski S; Garofalo C; Kanczuga-Koda L; Sulkowska M; Surmacz E
    Horm Metab Res; 2003; 35(11-12):794-801. PubMed ID: 14710360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.